Papers by Sambit Das · AgingResearch.News

Indian Journal of Endocrinology and Metabolism26 Sep
Efficacy of Dapagliflozin vs. Saroglitazar on Hepatic Steatosis and Fibrosis in Patients of Type 2 Diabetes Mellitus and Metabolic-Associated Steatotic Liver Disease (MASLD)
Randomised trial in 101 peopleDapagliflozin
Paper
Diabetes Research and Clinical Practice25 Aug
Efficacy of dapagliflozin on hepatic steatosis and fibrosis in patients with type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease: a pre-specified single-arm analysis from a randomized controlled trial
Non-randomised trial in 54 peopleDapagliflozin
Paper
Metabolism Open14 Aug
Efficacy and safety of semaglutide injection in Indian patients with type 2 diabetes mellitus inadequately controlled on metformin: A phase 3, randomized, active-controlled, multicenter, non-inferiority trial (WIN-IND study)
Randomised trial in 223 peopleSemaglutide
Paper
Frontiers in Clinical Diabetes and Healthcare4 Aug
Dapagliflozin & pioglitazone combination therapy in T2DM with or without MASLD - a systematic review and meta-analysis: PRO-2 study
ReviewInterventions
Paper

ADA Scientific Sessions 2026 Abstract6 Jun
STEP UP T2D: Participants Achieving BMI, WHtR, and Cardiometabolic Treatment Targets
Trial in peopleInterventions
Paper